Survival of patients with prostate cancer

Objective: To analyze the survival after five years among patients treated of prostate cancer at Hospital São Marcos. Methods: A descriptive population-based epidemiological study performed in Teresina-PI, evaluating a hospital cohort consisting of 71 patients of Hospital São Marcos, enrolled in Hos...

Full description

Bibliographic Details
Main Authors: Fabienne Camilo da Silveira Pirajá, Rafael Bandeira Lages, Uylma Assunção Costa, João Batista Mendes Teles, Viriato Campelo
Format: Article
Language:Portuguese
Published: Universidade de Fortaleza 2013-08-01
Series:Revista Brasileira em Promoção da Saúde
Subjects:
Online Access:http://ojs.unifor.br/index.php/RBPS/article/view/2617
id doaj-4eb542230b7e4463afa7fbb797c5be3a
record_format Article
spelling doaj-4eb542230b7e4463afa7fbb797c5be3a2020-11-24T22:24:05ZporUniversidade de FortalezaRevista Brasileira em Promoção da Saúde1806-12221806-12302013-08-01261444910.5020/26172911Survival of patients with prostate cancerFabienne Camilo da Silveira Pirajá0Rafael Bandeira Lages1Uylma Assunção Costa2João Batista Mendes Teles3Viriato Campelo4Universidade Federal do Piauí - UFPIUniversidade Federal do Piauí (UFPI)Universidade Federal do Piauí (UFPI)Universidade Federal do Piauí (UFPI)Universidade Federal do Piauí (UFPI)Objective: To analyze the survival after five years among patients treated of prostate cancer at Hospital São Marcos. Methods: A descriptive population-based epidemiological study performed in Teresina-PI, evaluating a hospital cohort consisting of 71 patients of Hospital São Marcos, enrolled in Hospital Cancer Registry (HCR) from 2000 to 2001, under ICD10 -C61. The variables considered in the evaluation of survival were: age group, tumor staging and skin color. The Kaplan-Meier method was used in the calculation of survival functions in five years and the Kruskal-Wallis test in comparison between variables. Results: The specific survival rate for prostate cancer was of 78.5% in five years. The death risk in this study increased with age and advanced stage at diagnosis (aged 80 or above = 60%; and stage IV = 63%). The Kruskal-Wallis test showed no statistically significant variation between groups. Conclusion: The age and advanced stage at diagnosis decreased patients’ survival.http://ojs.unifor.br/index.php/RBPS/article/view/2617Neoplasias da PróstataAnálise de SobrevidaDoenças Prostáticas.
collection DOAJ
language Portuguese
format Article
sources DOAJ
author Fabienne Camilo da Silveira Pirajá
Rafael Bandeira Lages
Uylma Assunção Costa
João Batista Mendes Teles
Viriato Campelo
spellingShingle Fabienne Camilo da Silveira Pirajá
Rafael Bandeira Lages
Uylma Assunção Costa
João Batista Mendes Teles
Viriato Campelo
Survival of patients with prostate cancer
Revista Brasileira em Promoção da Saúde
Neoplasias da Próstata
Análise de Sobrevida
Doenças Prostáticas.
author_facet Fabienne Camilo da Silveira Pirajá
Rafael Bandeira Lages
Uylma Assunção Costa
João Batista Mendes Teles
Viriato Campelo
author_sort Fabienne Camilo da Silveira Pirajá
title Survival of patients with prostate cancer
title_short Survival of patients with prostate cancer
title_full Survival of patients with prostate cancer
title_fullStr Survival of patients with prostate cancer
title_full_unstemmed Survival of patients with prostate cancer
title_sort survival of patients with prostate cancer
publisher Universidade de Fortaleza
series Revista Brasileira em Promoção da Saúde
issn 1806-1222
1806-1230
publishDate 2013-08-01
description Objective: To analyze the survival after five years among patients treated of prostate cancer at Hospital São Marcos. Methods: A descriptive population-based epidemiological study performed in Teresina-PI, evaluating a hospital cohort consisting of 71 patients of Hospital São Marcos, enrolled in Hospital Cancer Registry (HCR) from 2000 to 2001, under ICD10 -C61. The variables considered in the evaluation of survival were: age group, tumor staging and skin color. The Kaplan-Meier method was used in the calculation of survival functions in five years and the Kruskal-Wallis test in comparison between variables. Results: The specific survival rate for prostate cancer was of 78.5% in five years. The death risk in this study increased with age and advanced stage at diagnosis (aged 80 or above = 60%; and stage IV = 63%). The Kruskal-Wallis test showed no statistically significant variation between groups. Conclusion: The age and advanced stage at diagnosis decreased patients’ survival.
topic Neoplasias da Próstata
Análise de Sobrevida
Doenças Prostáticas.
url http://ojs.unifor.br/index.php/RBPS/article/view/2617
work_keys_str_mv AT fabiennecamilodasilveirapiraja survivalofpatientswithprostatecancer
AT rafaelbandeiralages survivalofpatientswithprostatecancer
AT uylmaassuncaocosta survivalofpatientswithprostatecancer
AT joaobatistamendesteles survivalofpatientswithprostatecancer
AT viriatocampelo survivalofpatientswithprostatecancer
_version_ 1725762342369624064